Alerts will be sent to your verified email
Verify Email
EMCURE
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Emcure Pharmaceuticals is one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. The company’s core strength and competitive advantage lie in its established presence in all major therapeutic areas including Gynaecology, cardiology, blood-related, oncology, respiratory, CNS & HIV among others.
Emcure Pharma major competitors are Pfizer, Onesource Specialty, Eris Lifesciences, Astrazeneca Pharma I, Wockhardt, Alembic Pharma, Neuland Laboratories.
Market Cap of Emcure Pharma is ₹19,388 Crs.
While the median market cap of its peers are ₹19,399 Crs.
Emcure Pharma seems to be less financially stable compared to its competitors.
Altman Z score of Emcure Pharma is 4.34 and is ranked 6 out of its 8 competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | Sep Dec | |||||||||||||||||
| Investor Presentation | ||||||||||||||||||
| Conference Call | Jun Sep Dec | |||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
